Had Theranos' technology not been a mirage, the company might have been on the leading edge of a massive boom in patient-driven testing.
The Pandemic Offers Self-Testing a Comeback
Comment
Show comments
Hide Comments
Had Theranos' technology not been a mirage, the company might have been on the leading edge of a massive boom in patient-driven testing.
